Vir Biotechnology (VIR) is advancing its ECLIPSE phase 3 program for tobevibart + elebsiran in Hepatitis Delta Virus, with topline data from all 3 studies expected Q1 2027. Company's dual-masked ...
(MENAFN- EIN Presswire) EINPresswire/ -- Goody PR agency is honored to receive two top 2025 MarCom Awards – Platinum level for two categories: 1. Best Public Relations Program and 2. Best Publicity ...
Institute of Reading Development announces an online tutoring solution proven to boost K–5 reading skills and confidence. PETALUMA, Calif., Nov. 4, 2025 /PRNewswire/ -- America's reading crisis is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback